Drug, Anti-infective Market 2020 Analysis of the World's Leading Suppliers, Sales, Trends and Forecasts up to 2026

New Study Reports "Drug, Anti-infective Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

PUNE, MAHARASHTRA, INDIA, June 5, 2020 /EINPresswire.com/ — Drug, Anti-infective Market 2020-2026

New Study Reports "Drug, Anti-infective Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Drug, Anti-infective Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Drug, Anti-infective Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Drug, Anti-infective market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

This report also analyzes the impact of Coronavirus COVID-19 on the Drug, Anti-infective industry.

Key Players

The report has profiled some of the Important players prevalent in the global like – GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, Roche Pharma AG, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo, MerLion Pharma, Theravance, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Drug, Anti-infective.

Request for Free Sample Report of “Drug, Anti-infective” Market @  https://www.wiseguyreports.com/sample-request/5390692-covid-19-impact-on-drug-anti-infective-market-global-research-reports-2020-2021

Market Segmentation based On Type, Application and Region:

The global Drug, Anti-infective is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on Type, the global Drug, Anti-infective Market is segmented into OTC, Rx Drugs and other

Based on Application, the Drug, Anti-infective Market is segmented into Hospital, Drugs Store, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Drug, Anti-infective in each regional segment mentioned above.

Key Stakeholders 
Drug, Anti-infective Market Manufacturers 
Drug, Anti-infective Market Distributors/Traders/Wholesalers 
Drug, Anti-infective Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5390692-covid-19-impact-on-drug-anti-infective-market-global-research-reports-2020-2021

Major Key Points from Table of Content:

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug, Anti-infective Industry
1.7 COVID-19 Impact: Drug, Anti-infective Market Trends

7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Business Overview
7.1.2 GlaxoSmithKline Drug, Anti-infective Quarterly Production and Revenue, 2020
7.1.3 GlaxoSmithKline Drug, Anti-infective Product Introduction
7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.2 Merck
7.2.1 Merck Business Overview
7.2.2 Merck Drug, Anti-infective Quarterly Production and Revenue, 2020
7.2.3 Merck Drug, Anti-infective Product Introduction
7.2.4 Merck Response to COVID-19 and Related Developments
7.3 Pfizer
7.3.1 Pfizer Business Overview
7.3.2 Pfizer Drug, Anti-infective Quarterly Production and Revenue, 2020
7.3.3 Pfizer Drug, Anti-infective Product Introduction
7.3.4 Pfizer Response to COVID-19 and Related Developments
7.4 Novartis AG
7.4.1 Novartis AG Business Overview
7.4.2 Novartis AG Drug, Anti-infective Quarterly Production and Revenue, 2020
7.4.3 Novartis AG Drug, Anti-infective Product Introduction
7.4.4 Novartis AG Response to COVID-19 and Related Developments

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Equilibrium Wealth Advisors, LLC Launches as An Independent Registered Investment Advisor

Equilibrium Wealth Advisors, LLC is dedicated to helping our clients live their lives in balance and achieve their financial goals.

Dedicated to Simplifying the Complex Financial and Wealth Management Needs of Physicians, Business Owners, Corporate Leaders and Retirees

PITTSBURGH, PA, USA, June 5, 2020 /EINPresswire.com/ — Equilibrium Wealth Advisors, LLC (“EWA, LLC”) has transitioned its wealth management and financial planning practice to an independent Registered Investment Advisory (RIA) firm. Based in Pittsburgh, Pennsylvania, the newly formed firm was co-founded by Matthew Blocki, CFP®, RICP®, ChFC® and Jake McCracken, CFP®, both of whom are highly-respected and well-established wealth management and investment advisors in western Pennsylvania. Equilibrium Wealth Advisors was formerly affiliated with Northwestern Mutual.

Over the past decade, the EWA team has developed a specialty in advising physicians with the unique financial planning and wealth management challenges that arise throughout their careers, from their residencies to establishing successful practices and retirement. The EWA team also applies its comprehensive approach to the challenges faced by business owners, corporate leaders and retirees.

“Our firm is distinctive, so after extensive due diligence and careful consideration, we decided to become an independent firm to better serve our clients’ needs and interests,” says co-founder and CEO Matt Blocki. “As an RIA, we now have greater control over the services we offer and we can provide a broad range of research, products and solutions to our clients and support their goals.”

Co-founder Jake McCracken concurs. “We strive to help our clients keep their lives in balance. Our firm brings an integrated, stress-free approach to help them focus on both their current lives and their future goals. Our highest priority is to provide our clients with the best value in the context of transparency.”

The EWA team consists of seven professionals, five of whom are CERTIFIED FINANCIAL PLANNERS™. Each team member brings a depth of experience and acumen to their client interactions. EWA team members include:
• Matthew Blocki, CFP®, RICP®, ChFC®, Co-Founder and CEO, Wealth Advisor
• Jake McCracken, CFP®, Co-Founder and Wealth Advisor
• Nick Stonesifer, CFP®, ChFC®, Portfolio Manager
• Trevor York, CFP®, RICP®, Wealth Advisor and Chief Compliance Officer
• Grace Holt, CFP®, Chief Operating Officer
• Nancijo Pruce, RICP®, Client Relationship Manager
• Christopher Pavcic, Client Relationship Manager

EWA has moved to new offices at 381 Mansfield Road, Suite #200A, Pittsburgh, PA 15220. More information about the range of services offered by EWA can be found at EWA-LLC.com or by calling 412-288-2363.

Grace Holt
EWA LLC
+1 412-288-2363
email us here


Source: EIN Presswire

Medical Syringes and Needles Market 2020 Analysis by Trends, Demand, Products and Technology Forecast to 2026

New Study Reports "Medical Syringes and Needles Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added .

PUNE, MAHARASHTRA, INDIA, June 5, 2020 /EINPresswire.com/ — MEDICAL SYRINGES AND NEEDLES MARKET 2020-2026

New Study Reports "Medical Syringes and Needles Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Medical Syringes and Needles Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Syringes and Needles Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Medical Syringes and Needles market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

This report also analyzes the impact of Coronavirus COVID-19 on the Medical Syringes and Needles industry.

Key Players

The report has profiled some of the Important players prevalent in the global like – BD, B Braun, Gerresheimer, Schott, Nipro, Weigao, Stevanato, Terumo, Taisei Kako, Feeltech, Owen Mumford, Cardinal Health, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Medical Syringes and Needles.

Request for Free Sample Report of “Medical Syringes and Needles” Market @  https://www.wiseguyreports.com/sample-request/5387240-impact-of-covid-19-outbreak-on-medical-syringes

Market Segmentation based On Type, Application and Region:

The global Medical Syringes and Needles is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on Type, the global Medical Syringes and Needles Market is segmented into Syringes, Needles and other

Based on Application, the Medical Syringes and Needles Market is segmented into Vaccine, Biologics, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Medical Syringes and Needles in each regional segment mentioned above.

Key Stakeholders 
Medical Syringes and Needles Market Manufacturers 
Medical Syringes and Needles Market Distributors/Traders/Wholesalers 
Medical Syringes and Needles Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5387240-impact-of-covid-19-outbreak-on-medical-syringes

Major Key Points from Table of Content:

1 Medical Syringes and Needles Market Overview
1.1 Product Overview and Scope of Medical Syringes and Needles
1.2 Covid-19 Impact on Medical Syringes and Needles Segment by Type
1.2.1 Global Medical Syringes and Needles Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Syringes
1.2.3 Needles
1.3 Covid-19 Impact on Medical Syringes and Needles Segment by Application
1.3.1 Medical Syringes and Needles Consumption Comparison by Application: 2020 VS 2026
1.3.2 Vaccine
1.3.3 Biologics
1.3.4 Others
1.4 Covid-19 Impact on Global Medical Syringes and Needles Market by Region
1.4.1 Global Medical Syringes and Needles Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Covid-19 Impact on Global Medical Syringes and Needles Growth Prospects
1.5.1 Global Medical Syringes and Needles Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Medical Syringes and Needles Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Medical Syringes and Needles Production Estimates and Forecasts (2015-2026)
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 The Covid-19 Impact on Medical Syringes and Needles Industry
1.8 COVID-19 Impact: Medical Syringes and Needles Market Trends

7 Covid-19 Impact on Company Profiles and Key Figures in Medical Syringes and Needles Business
7.1 BD
7.1.1 BD Medical Syringes and Needles Production Sites and Area Served
7.1.2 BD Medical Syringes and Needles Product Introduction, Application and Specification
7.1.3 BD Medical Syringes and Needles Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 BD Main Business and Markets Served
7.2 B Braun
7.2.1 B Braun Medical Syringes and Needles Production Sites and Area Served
7.2.2 B Braun Medical Syringes and Needles Product Introduction, Application and Specification
7.2.3 B Braun Medical Syringes and Needles Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 B Braun Main Business and Markets Served
7.3 Gerresheimer
7.3.1 Gerresheimer Medical Syringes and Needles Production Sites and Area Served
7.3.2 Gerresheimer Medical Syringes and Needles Product Introduction, Application and Specification
7.3.3 Gerresheimer Medical Syringes and Needles Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Gerresheimer Main Business and Markets Served
7.4 Schott
7.4.1 Schott Medical Syringes and Needles Production Sites and Area Served
7.4.2 Schott Medical Syringes and Needles Product Introduction, Application and Specification
7.4.3 Schott Medical Syringes and Needles Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Schott Main Business and Markets Served

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Medical Gloves Market Size to Reach Revenues of Around $17 Billion by 2025 – Arizton

This market research report covers global medical gloves market size and growth, share, trends, drivers, and vendor analysis.

CHICAGO, ILLINOIS, UNITED STATES, June 5, 2020 /EINPresswire.com/ — The medical gloves market size is expected to grow at a CAGR of over 15% during the period 2019–2025.

In-depth analysis and data-driven insights on the impact of COVID-19 included in this global medical gloves market report. The global medical gloves market is growing at a healthy rate. The growth can be attributed to the growing demand for safety and hygiene standards to prevent the risk of contamination and infections in healthcare settings during medical and treatment measures. The growth in surgical procedures for several diseases and potential risk reduction for surgical site infection (SSI) is likely to fuel the market growth.

Health care professionals will continue to demand the latest medical gloves to treat acute and chronic diseases, which will promote safe and effective treatment outcomes. The emergence of new pandemic challenges such as COVID-19 will drive the future growth of the market. A strong preference for non-powdered medical gloves is also likely to drive future market growth.

Key Highlights Offered in the Report:
1. The global medical gloves market is expected to reach to about $324 billion by 2020 with high YoY growth of around 21% due to the recent COVID-19 pandemic.
2. As an effective preventive measure to stop coronavirus containment, wearing medical gloves with proper hygiene practice is gaining prominence during the pandemic.
3. Medical gloves made of nitrile material are expected to witness highest growth rate during the forecast period.
4. In terms of both volume shipment and revenue, medical gloves used in laboratory testing applications contributed to the maximum global medical gloves market share in 2019.
5. Growing preference for non-powdered gloves globally is another key factor propelling the market growth.
6. Practice of double gloving in healthcare settings is further contributing to the growth of global medical gloves market.
7. North America is leading the global market and accounted for a volume share of around 32% in 2019, followed by Europe, APAC, Middle East & Africa, and Latin America.

Key Offerings:
• Market Size & Forecast by Revenue | 2019−2025
• Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
• Market Segmentation – A detailed analysis by material, application, category, end-user, and geography
• Competitive Landscape – Profile of 8 key vendors and 43 other vendors

Get your sample today!

The following factors are likely to contribute to the growth of the medical gloves market during the forecast period:
• Emergence of New Pandemic Challenge
• Progressive Emphasis on Stringent Health Regulations across Regions
• Increased Focus on Safety and Hygiene Standards
• Growth in Surgical Procedures

The study considers the present scenario of the medical gloves market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market. The research report covers the market in terms of revenue and volume forecast.

Medical Gloves Market Segmentation

This research report includes a detailed segmentation by Material, Application, Category, End-user, and geography. The nitrile gloves segment is expected to grow at a healthy CAGR during the forecast period. The demand for nitrile gloves is increasing due to the number of benefits, including alleviating allergies and increased chemical and puncture resistance. Manufacturers are preparing nitrile ones as comfortable as latex with improved quality. Hence, manufacturers are increasingly focusing on developing a new type of accelerator-free nitrile gloves. They contain less chemicals and are stronger than traditional nitrile ones without compromising comfort. With the ongoing shift from latex to nitrile, manufacturers reported high sales from nitrile gloves in 2019.

The global examination medical gloves market is expected to reach over $10 billion by 2025. The growing demand from the healthcare industry is a major factor contributing to the growth. The increasing usage of examination gloves to prevent healthcare professionals from the transmission of infectious agents is another driver, which is influencing the growth. These are made of latex, nitrile, and vinyl. Latex and nitrile exam gloves are often used when dealing with high-risk situations involving blood, body fluids, or patients with infectious diseases such as COVID-19 pandemic.

The powder-free medical gloves segment accounts for the largest market share as a majority of commercially available medical gloves are non-powdered ones. The demand is expected to grow at a steady rate primarily due to the low risk of infections. Several medical studies have stated that powder-free gloves are considered cleaner than powdered ones. This characteristic has increased the popularity and demand from the healthcare industry. With the rising importance of powder-free ones, vendors are strategizing to offer innovative gloves with best-in-class manufacturing procedures.

In terms of revenue, hospitals and diagnostic laboratories are the major end-users in the medical gloves market. The segment is growing at a healthy rate and is likely to grow during the forecast period. This is primarily due to the high adoption of the latest generation treatment practices with standard hygiene and safety measures. The aging population and the increasing pool of patients with diseases such as CVDs, COPD, neurovascular diseases, gynecological diseases, cancer, orthopedic ailments are the major factors driving the growth of the hospital segment.

The diagnostic laboratories end-user segment accounted for over 29% share of the global market. The segment is growing at a healthy rate majorly due to the widespread usage in laboratory settings. Research professionals use examination medical gloves in these settings. The segment includes both public health laboratories and reference laboratories. In the recent outbreak of COVID-19 pandemic, diagnostic laboratories have been on the front line of the battle against the virus, providing specimen collection, coordinating supplies, and offering testing facilities.

Segmentation by Material
• Latex
• Nitrile
• Vinyl
• Neoprene
• Others
By Application
• Examination
• Surgical
By End-user
• Hospital
• Diagnostic Laboratories
• ASCs
• Clinics
• Others
By Category
• Non-powdered/powder-free
• Powdered

Insights by Geography

The North American market is expected to grow at a CAGR of over 15% during the period 2019¬–2025. The region is characterized by high penetration of advanced treatment solutions for chronic and acute diseases, advancements in material such as latex-free non-allergic gloves. With the favorable government financial support for several surgical procedures results in the higher uptake of surgeries as well as surgical gloves. North America offers tremendous growth opportunities; therefore, the market is expected to continue to grow during the upcoming period. The US is the major revenue contributor to the global market. The country holds the highest value due to better healthcare facilities and medical coverage and spending. The US medical gloves market is growing at a significant rate and is likely to grow during the forecast period.

Get your sample today! https://www.arizton.com/market-reports/medical-gloves-market

By Geography
• North America
o Canada
o US
• Europe
o UK
o Germany
o France
o Italy
o Spain
• APAC
o China
o Japan
o South Korea
o Australia
o India
• Latin America
o Brazil
o Mexico
o Argentina
o Columbia
o Chile
• Middle East & Africa
o South Africa
o Saudi Arabia
o Turkey
o Iran

Insights by Vendors

The global medical gloves market share is very fragmented and is highly competitive, and dynamic characterized by the presence of many global, regional, and local vendors. The vendors are offering a diverse range of medical gloves for both examination and surgical applications. Large and diversified companies accounts for major shares. Also, most key players – Top Glove, Ansell, Kossan Rubber Industries, Hartalega Holdings, Supermax – have demonstrated consistent growth over the last few years.

Prominent Vendors
• Top Glove
• Kossan Rubber Industries
• Hartalega Holdings
• Semperit
• Cardinal Health
• Supermax
• Braun Melsungen

Other Prominent Vendors
• ACTEON
• ADVENTA Health
• AKZENTA INTERNATIONAL
• AlboLand
• ASID BONZ
• BERNER International
• Body Products
• BSN Medical
• CEABIS
• DIDACTIC
• Demophorius Healthcare
• Elcya
• ERENLER MEDİKAL
• Franz Mensch
• Gemma
• Hepro.us
• HUM GmbH
• Hygeco
• Intco Medical
• International Biomedical
• KALTEK
• Kanam Latex Industries
• Leboo Healthcare Products
• Low Derma
• Medadv
• Medibase
• Mölnlycke Health Care
• MRK Healthcare
• Neomedic
• Pidegree Industrial
• Polyco Healthline
• RFB Latex
• Riverstone Holdings
• Robinson Healthcare
• SHIELD Scientific
• Smart Glove
• Sri Trang Agro-Industry
• TROGE MEDICAL
• Unigloves
• Winmed Group
• WRP Asia Pacific
• Wujiang Evergreen
• YTY Group

Key Questions Answered
1. What is the market size of the medical gloves market?
2. What are the factors impacting the growth of the disposable gloves market?
3. What are the drivers, trends, and restraints in the market?
4. Who are the leading vendors in the surgical gloves market and what are their market shares?
5. What is the impact of the COVID-19 pandemic on the surgical gloves market?

Looking for more information? Click Here

Jessica
Arizton Advisory and Inteligence
+1 312-235-2040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Mademoiselle Lash Launches Wedding Eyelash Collection for Brides

One of the nation’s leading false eyelashes companies has unveiled new bundles of false eyelashes for brides.

COSTA MESA, CALIFORNIA, US, June 5, 2020 /EINPresswire.com/ — Representatives with Costa Mesa, CA-based Mademoiselle Lash have announced that the company has launched a wedding collection of false eyelashes for brides.

“We are excited to add natural-looking wedding collection of false eyelashes,” said Annie Le, owner and Creative Director of Mademoiselle Lash.

“The wedding lash bundles contain three sets of beautiful eyelashes, specially chosen to take you from aisle to reception to after-party,” revealed Le.

Mademoiselle Lash’s online store has two bundles of unique wedding eyelashes, and they are Wedding Day to Night Round Lash Bundle and Wedding Day to Night Winged Lash Bundle.

Le went on to highlight that each wedding eyelash bundle includes a subtler, more natural-looking version for daytime, a high-octane glamor one for the evening, and the third set of lashes that is somewhere in between.

Mademoiselle Lash’s Wedding Day to Night Round Lash Bundle consists of three different types of fake eyelashes: Lavonne, Emma, and Jenai lashes.

Le explained that Lavonne Lashes are great for a gorgeously natural daytime look while Emma Lashes are longer and fuller and ideals for wedding photoshoots. Jenai Lashes have a full, feathery volume, and nothing short of sensational.

The company’s Wedding Day to Night Winged Lash Bundle also has three different types of beautiful eyelashes – Mila, Thuy, and Tina.

“Mila Lashes say “I do” in the most enchanting way possible, with these wonderfully natural-looking eyelashes,” said Le. “Thuy Lashes are more voluminous than the Mila lashes and have a more pronounced cat-eye shape while Tina Lashes have 15mm of luscious length and an unmistakable cat-eye flick which makes you the most breathtaking woman in the room – just as any bride should be!”

“Even if you’re not getting married, you’ll love the day-to-night versatility of these two lash multipacks!” said Le.

As to what makes Mademoiselle lashes different from other products on the market, Le highlighted, “The difference is in our designs & quality of the product. Many makeup artists, influencers, and customers comment on how fluffy our styles are.”

“Most brands focus on one style of lashes – either only dramatic or only natural. We offer multiple styles of lashes include the classic length, extended volume lashes & natural lashes. We also offer different bands so that our customers can find the most comfortable lashes for them.”

For more information, please visit https://www.mademoisellelash.com/ and https://www.mademoisellelash.com/blogs/all-about-lashes

###

About Mademoiselle Lash

We may be biased, but we genuinely believe it when we say that Mademoiselle Lash is one of the best false eyelash brands in the industry. Perhaps even the best. Based in Orange County, CA, it’s our mission to design faux eyelashes that are so good; you’ll consider them a must-have accessory in your beauty cabinet.

We were created with a philosophy to spread the love of beauty to all. From premium-quality materials and construction to a range that includes a lash style to suit every eye shape, we won’t be satisfied until everyone who wears false eyelashes calls us their favorite.

Media Contact:

Annie Le

Owner and Creative Director

Mademoiselle Lash
Phone: 1- 949-484-8450

Source: Mademoiselle Lash

Annie Le
Mademoiselle Lash
+1 949-484-8450
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

U.S. Pharmacy Benefit Management Market Size to Reach Revenues of over $700 Billion by 2025 – Arizton

The U.S. pharmacy benefit management market is expected to grow at a CAGR of over 7% during the period 2019–2025.

CHICAGO, ILLINOIS, UNITED STATES, June 5, 2020 /EINPresswire.com/ — In-depth analysis and data-driven insights on the impact of COVID-19 included in this US pharmacy benefit management market report.

The US pharmacy benefit management market is expected to grow at a CAGR of over 7% during the period 2019–2025.

Key Highlights Offered in the Report:
1. The expensiveness and lack of transparency in the current medical system in the US has driven up dependence on healthcare system and lead to costs spiraling out of control. This is driving demand for pharmacy benefit management (PBM) to help stem costs.
2. Plan sponsors are looking at supplemental benefits that can help to reduce medical cost burden and drive better outcomes beyond the regular pharmacy and medical benefits. Digital health solutions from PBMs are thereby in demand.
3. PBMs have been tangled in the bureaucracy. They are being criticized as contributing to the ineffectiveness, expensiveness, and bad service of the US healthcare system at the behest of pocketing profits.
4. PBMs are reinventing themselves and reinforcing the roles they play in the healthcare system by shifting from a siloed mindset to vertical integration by combining with specialty pharmacies and insurers.
5. The future of PBMs is going to be dictated by the implementation of state and national-level policies with respect to revenue streams and business practices in the pharmaceutical space.

Key Offerings:
• Market Size & Forecast by Revenue | 2019−2025
• Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
• Market Segmentation – A detailed analysis by services, health plan, and business model
• Competitive Landscape – Profile of 7 key vendors and 31 other vendors

Get your sample today!

The U.S. healthcare landscape is complex. It is riddled with wastage, drug abuse, and fraud due to a whirlwind of causative factors, putting patients at risk and creating a dilemma for insurers. It translates to high out-of-pocket costs, increased incidences of inappropriate spending, higher premiums, reduced benefits or coverage for consumers, increases cost of doling out insurance benefits for governments, and private employers. With a high number of consumers being enrolled in high-deductible health plans, there is a need for coordinated and broad effort to fix loopholes. Pharmacy benefit managers are well-positioned as patients advocate to work with players across the board, with every member in the healthcare industry. PBM pharmacists can witness a complete picture of the member’s medication background. This has enabled them to drive awareness among pharmacists and doctors/physicians to identify challenges and enable the delivery of better treatment through better communication and care coordination across the healthcare continuum for each patient.

The following factors are likely to contribute to the growth of the pharmacy benefit management market in US during the forecast period:
• Foray into Digital Health Solutions
• Growth in FDA Approvals for Orphan and Specialty Drugs
• Shift to Value/Outcomes-based Contracts
• Increased Engagement in High-touch Care Management

The study considers the present scenario of the pharmacy benefit management market in US and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Pharmacy Benefit Management Market in US: Segmentation

This research report includes a detailed segmentation by services, health plan, and business model. Specialty pharmacy – a segment of the U.S. Pharmacy Benefit Management market, which is a collaborative, clinical, integrated environment, is recording significant growth in the US pharmacy benefit management market. The segment has cemented its place in the continuum of healthcare, backed by a healthy level of activity in payer access and data systems. As specialty drugs have outpaced all the other elements of healthcare costs, the segment is keeping payers on the edge of their seats. Since specialty pharmacies and mail-order pharmacies operate on a similar model in terms of medication deliveries. There are apprehensions about conflicts of interest and about how PBMs tag specific drugs as “specialty.”
Drugs, which treat auto-immune conditions, are growing at the fastest rate in commercial health plans. With emerging therapies that come at a high cost, the per-member, per-month spending on these therapies has witnessed an upward trend over the past couple of years. The increased focus of commercial health plan providers is on monitoring use and keeping the cost of drugs in check. This has led to an increased focus on utilization monitoring and formulary design, driving better prospects for the segment.
Commercial plan sponsors are also looking to increase resources to help employees access behavioral and mental health services as they struggle with maintaining the usefulness of prescription management services. The enrollment in Medicare Part D plans has grown 2X times over the last 15 years. Seeing as Medicare is designed to absorb risk, providing for individuals with complex, expensive medical needs, along with relatively healthy individuals, these plans rely heavily on PBMs.
The Pharmacy benefit management market in US is well backed, fortifying future growth by ramping up the capital investment in data analytics capabilities and technology R&D. As employers continue to concentrate on whole-person health, providing a total benefits solution, which is vital to draw and keep talent, this segment is expected to grow.
As insurance companies launch new products for gene therapies, they are considering offering therapy management techniques. The key players in the market are keeping a tab on the gene therapy pipeline and tracing patient outcomes, which are being used as a starting point for value-based arrangements that the company is on with pharma manufacturers. This is drawing attention, particularly from employers, creating favorability for players with these business models. The pharmacy benefit management market in US is highly fragmented.

By Health Plans
• Commercial Health Plan
• Self-insured Employer Plan
• Medical Part D Plans
• Managed Medicaid Programs
• Other
By Services
• Specialty Pharmacy Services
• Retail Pharmacy Services
• Mail-order Pharmacy Services
• Benefit Plan Design & Administration
• Formulary Management
• Clinical Programs & Services
• Others
By Business Model
• Insurance Companies & Retail Pharmacies
• Pure Play PBMs

Get your sample today! https://www.arizton.com/market-reports/pharmacy-benefit-management-market-in-united-states

Insights by Vendors

The Pharmacy Benefit Management market in US share has changed considerably in the last couple of years, where acquisitions led the market to where it is today, occupied mostly by a couple of giants. As a result, the PBM industry is highly concentrated with Caremark, Express Scripts, and OptumRX, accounting for more than 70% of claims volume. They have been the shapeshifters in the PBM space. However, that again is changing as insurers have been building their presence in the market by dissolving existent relationships with PBMs and acquiring or launching their own.

Key Vendors
• CVS Caremark
• Express Scripts
• OptumRx
• Humana Pharmacy Solutions

Other Prominent Vendors
• Abarca Health
• Anthem
• AscellaHealth
• BeneCard PBF
• Centene
• Citizens Rx
• EnvisionRxOptions
• Excelera
• Magellan Rx Management
• MedalistRx
• MedImpact
• Prime Therapeutics
• MaxorPlus
• Navitus Health Solutions
• Perform Rx
• RxAdvance
• WellDyneRx

Key Questions Answered
1. What is the U.S. Pharmacy Benefit Management Market Size in 2020?
2. What is the growth rate (CAGR) of the U.S. PBM Market during 2020-2025?
3. Which is the leading segment of the U.S. PBM Market?
4. Impact of COVID-19 on the Pharmacy Benefits Management Market in the U.S.?

Looking for more information? Click Here

Jessica
Arizton Advisory and Inteligence
+1 312-235-2040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Dr. Randall Gibb Shares His Insight On How The Healthcare Community Is Being Assisted By Technology

BILLINGS, MONTANA, UNITED STATES, June 5, 2020 /EINPresswire.com/ — With Technology changing at a rapid pace year after year the healthcare community has been very positively impacted and is taking advantage of these advances during the COVID-19 pandemic. Dr. Randall Gibb, a Gynecologic Oncologist based in Billings Montana, recently shared his insights on this subject with the readers of https://bitrebels.com/.

Dr. Gibb shares his views on recent technology innovations, such as Telemedicine. This new advance to our healthcare system has been more widely accepted throughout the recent pandemic. At a time when families are asked to stay home, stay away from the hospital and healthcare providers unless absolutely necessary. Telehealth has made it possible to speak with your doctor or nurse and in some cases have a virtual face to face visit to visually evaluate the patient.

In addition to this newly embraced opportunity to speak to a medical professional from the comfort of your home telehealth has assisted in reducing the cost of doctor visits. Making it more affordable for those who’s healthcare was simply not enough to cover doctor visits this advance is allowing more families to connect with their doctors when they might otherwise have waited and ended up with a more serious condition.

Dr. Gibb continues to share that with the ease of virtual visits and electronic medical records our medical providers can assist us from virtually anywhere. With medical records available for any medical professional to access patients can rest assured that their health care providers have the necessary information to be able to do the best job possible.

The COVID-19 Pandemic has tested our healthcare system and the technology, putting them to the ultimate real life test.

Connect with Dr Randy here: https://drrandallgibb.com/

About Dr. Randall Gibb

Dr. Randall Gibb began his training at the University of Illinois in Champaign/Urbana. He has built a distinguished career as a Gynecologic Oncologist and Health Care Administrator. He established himself as the first Gynecologic Oncologist in the state of Montana. Throughout his leadership and strategic planning he has saved thousands of lives. Dr. Gibb also extended his specialty services at clinics across several states by enabling patients to gain access to high quality healthcare.

Dr. Randall Gibb
Gynecologic Oncologist
+1 406-696-0780
email us here


Source: EIN Presswire

Virtual DBT and CBT Foundational Workshops will Prepare Mental Health Professionals to Deliver Evidence-Based Care

Evidenced Based Care Training in CBT and DBT for Psychologists, Psychiatrists, Social Workers, school counselors, nurses and other mental health professionals.

WHITE PLAINS, NEW YORK, UNITED STATES, June 5, 2020 /EINPresswire.com/ — Cognitive and Behavioral Consultants (CBC) will host two Foundational workshops: one for Cognitive Behavioral Therapy (CBT) and one for Dialectical Behavioral Therapy (DBT) using a state-of-the art virtual platform. The workshops will provide comprehensive training on evidence-based techniques and strategies for mental health professionals to help them meet the increased mental health needs in the community today and teach skills to engage clients using telehealth platforms.

The CBT workshop will be held July 6, 8,10,14 and 16 and is for mental health professionals and students interested in building and deepening their understanding of Cognitive Behavioral Therapy principles in clinical practice. Thirty-five Continuing Education Credit Hours will be offered to NY Social Workers and all Psychologists.

This intensive, comprehensive 5-day foundational training program in CBT, in its seventh year, is for mental health professionals without any background in CBT as well as early career professionals, and advanced clinicians who learned CBT through self-study, workshops or courses – to help them rigorously apply and implement CBT case conceptualization and strategies. Cognitive Behavioral Therapy represents an umbrella of therapies that have shown to be effective in treating a variety of conditions. The training will teach core skills in CBT across conditions and problems, including trauma, stress, worry and general anxiety, panic, agoraphobia, social anxiety, depression, OCD, externalizing conditions, and relationship problems. Upon completion attendees will have the required didactic hours to apply to become a Certified Diplomate though the Academy of Cognitive and Behavioral Therapies (A-CBT).

Course Director, Dr. Lata K. McGinn is a tenured Professor of Psychology and Director of the Clinical Program at the Ferkauf Graduate School of Psychology, Yeshiva University. Dr. McGinn has earned the title of Beck Scholar and was appointed a Fellow of the Association of Behavioral and Cognitive Psychotherapies (ABCT). Dr. McGinn is a founding fellow and certified trainer of the Academy of CBT, is the associate editor of the peer-reviewed journal Cognitive Therapy and Research and serves on the editorial board of several other peer-reviewed journals. In 2019, Dr. McGinn spearheaded a global initiative to found the World Confederation of Cognitive and Behavioral Therapies (WCCBT) and currently serves on its Board of Directors. She is also the Past-President of the Academy of CBT (A-CBT) and the International Association for Cognitive Psychotherapy (IACP), and has also served on ABCT’s Board of Directors.

The Dialectical Behavior Therapy (DBT) workshop, with an Adolescent-Family Emphasis, will take place August 31, September 2, 4, 8 and 10 and is for clinicians on existing consultation teams in agencies and schools. Thirty-five Continuing Education Credit Hours will be offered to NY Social Workers and all Psychologists.

CBC has become the first—and only, to date—Dialectical Behavior Therapy (DBT)-Linehan Board of Certification, Certified Program in New York State.

Dr. Alec Miller co-developed DBT for multi-problem and self-harming adolescents which has been established as an evidence-based treatment for this population. Dr. Miller and his colleagues will teach the theories, structure, and practice of the DBT model, including strategies for individual sessions, skills training groups, inter-session coaching, and the effective management of a consultation team. The instructors will utilize didactics, videos, role-play demonstrations and participant exercises. Research has shown DBT with adolescents to be effective in reducing self-harm behaviors, depression, hopelessness, dropout from treatment, psychiatric hospitalization, substance use and interpersonal difficulties.

Dr. Alec L. Miller is a clinical psychologist, teacher, researcher, author, and disseminator of evidence-based treatments to clinical and school settings worldwide. He has conducted federally funded clinical research and published extensively in DBT, including the three leading textbooks titled: Dialectical Behavior Therapy with Suicidal Adolescents; DBT Skills Manual for Adolescents; and DBT Skills in Schools (DBT STEPS-A). He was a lead trainer and co-investigator of the first randomized controlled trial of DBT with suicidal adolescents published in 2014. He has been internationally recognized and received awards for his teaching of clinicians about how to conduct DBT with adolescents and families.

Early registration rates, group and student discounts available. More information here http://cbc-psychology.com/training/continuing-education-for-mental-health-professionals or contact Saranda Krasniqi (914) 385-1150, skrasniqi@cbc-psychology.com

CBC, founded in 2004 by Dr. Lata McGinn and Dr. Alec Miller, is a clinical and training center with locations in New York comprised of internationally recognized mental health professionals. www.cbc-psychology.com

Saranda Krasniqi
Cognitive Behavioral Consultants
+1 914-385-1150
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

COVID-19 Rapid Test Kits Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026

A new market study, titled “Discover Global COVID-19 Rapid Test Kits Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, June 5, 2020 /EINPresswire.com/ — Introduction
“COVID-19 Rapid Test Kits Market”
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
This report presents a comprehensive overview, market shares, and growth opportunities of “COVID-19 Rapid Test Kits” market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the COVID-19 Rapid Test Kits, covering the supply chain analysis, impact assessment to the COVID-19 Rapid Test Kits market size growth rate in several scenarios, and the measures to be undertaken by COVID-19 Rapid Test Kits companies in response to the COVID-19 epidemic.

@Get a Free Sample Report “COVID-19 Rapid Test Kits Market” 2020 https://www.wiseguyreports.com/sample-request/5402816-global-covid-19-rapid-test-kits-market-growth-status-and-outlook-2020-2025
If you have any special requirements, please let us know and we will offer you the report as you want.

Key Players of Global COVID-19 Rapid Test Kits Market =>
• Cellex
• Mount Sinai Laboratory
• Abbott
• BioMedomics
• BD
• Roche
• Mayo Clinic Laboratories
• Henry Schein
• Chembio Diagnostics
• Safecare Bio-Tech
• Dynamiker Biotechnology (Tianjin)
• ADVAITE
• Ortho Clinical Diagnostics
• Guangzhou Wondfo Biotech
• Innovita Biological Technology
• Guangdong Hecin-Scientific
• Zhejiang Orient Gene Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Segmentation by product type:
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay

Segmentation by Application:
Hospitals
Scientific Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia

Research objectives
To study and analyze the global COVID-19 Rapid Test Kits market size by key regions/countries, type and application.
To understand the structure of COVID-19 Rapid Test Kits market by identifying its various subsegments.
Focuses on the key global COVID-19 Rapid Test Kits players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the COVID-19 Rapid Test Kits with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of COVID-19 Rapid Test Kits submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

@Ask Any Query on “COVID-19 Rapid Test Kits Market” 2020 Size, Share, demand https://www.wiseguyreports.com/enquiry/5402816-global-covid-19-rapid-test-kits-market-growth-status-and-outlook-2020-2025

Major Key Points of Global COVID-19 Rapid Test Kits Market
1 Scope of the Report
2 Executive Summary
3 COVID-19 Rapid Test Kits Key Players
4 COVID-19 Rapid Test Kits by Regions
5 Americas
6 APAC
9 Key Investors in COVID-19 Rapid Test Kits
10 Key Players Analysis
11 Research Findings and ConclusionList of Tables

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Nevada US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste to Ensure a Navy Veteran with Mesothelioma in Nevada Receives the Best Possible Compensation Results

"We have endorsed attorney Erik Karst of the law firm of Karst von Oiste to make certain a Navy Veteran with mesothelioma in Nevada receives the very best possible financial compensation results. ”

— Nevada US Navy Veterans Mesothelioma Advocate

LAS VEGAS, NEVADA, USA, June 5, 2020 /EINPresswire.com/ — The Nevada US Navy Veterans Mesothelioma Advocate says, "We have endorsed attorney Erik Karst of the law firm of Karst von Oiste to make certain a Navy Veteran with mesothelioma in Nevada receives the very best possible financial compensation results. Because of the Coronavirus many Navy Veterans or people with mesothelioma were initially diagnosed with pneumonia or as a possible victim of COVID-19. Erik Karst is one of the nation's leading mesothelioma attorneys and he is always happy to talk about compensation with a Navy Veteran with this rare cancer caused by asbestos exposure. For direct access to attorney Erik Karst of the law firm of Karst von Oiste please call 800-714-0303.

"The other reason we have endorsed attorney Erik Karst of the law firm of Karst von Oiste is because he is a fulltime-extremely skilled mesothelioma attorney, he and his amazing colleagues at KVO have been assisting Navy Veterans for decades, and they are responsible for over a billion dollars in financial compensation for people like this. If you are a Navy Veteran with mesothelioma in Nevada and you would like some honest information about mesothelioma compensation-please call 800-714-0303 for direct access to attorney Erik Karst. www.karstvonoiste.com/

The Nevada US Navy Veterans Mesothelioma Advocate offers their free services to US Navy Veterans with mesothelioma in Las Vegas, Henderson, Reno, Paradise, Enterprise, Carson City or anywhere in Nevada. https://Nevada.USNavyMesothelioma.Com

For the best possible mesothelioma treatment options in Nevada the Nevada US Navy Veterans Mesothelioma Advocate strongly recommends the following three heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* Comprehensive Cancer Clinic Las Vegas, Nevada: www.cccnevada.com

* The Huntsman Cancer Institute Salt Lake City, Utah: https://healthcare.utah.edu/

Every US Navy ship or submarine built prior to 1980 contained asbestos. About one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. Before a Navy Veteran with mesothelioma or their family retain the services of a lawyer or law firm, they are urged to call the US Navy Veterans Mesothelioma Advocate anytime at 800-714-0303. https://USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For a listing of various classes of US Navy ships or submarines please visit the US Navy website on this topic: https://www.navy.mil/navydata/our_ships.asp.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Nevada US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire